After the startups Recently, they have lost their ability to sell right copies of patented GLP-1 slimming drugs, some companies began to address other, less effective drugs that have been on the market in the United States since 2010. Often considered a precursor of hit products such as Meds Meds Prescription Aldscription, as well as Meds Meds Adession Eli Lilly. Venerable age.
Originally sold by Novo Nordisk under the brands of Victraza and Saxenda, the drug is available in general in the US since last year. Like ozempic, liraglutide is the GLP-1 agonist who imitates the naturally occurring hormone and works by suppressing hunger signals and regulating the level of insulin. But there is no same recognition or popularity as newer GLP-1 drugs for a very basic reason: it does not work either, it can cause more stern side effects, and patients must inject them every day, not every week.
At the beginning of this year, the FDA found that patented medicines such as Zepound and Ozmpic were no longer missing, ending the regulations that allowed online clinics to sell without a brand, intricate versions of medicines. When clinics and producers develop the sale of these associations, many internet clinics and producers accept lyreglutide. Leading Hims teo in addition General liraraglutide to their composition last month, joining a dozen or so competitors already offering the product in intricate, general or brand forms.
Enormous intricate pharmacies, such as Olympia Pharmaceuticals in Florida, are already aimed at making the drug, expecting the demand will raise. “We have signed quite large contracts for liraglutide,” says financial director Joshua Fritzler. “We can treat it in the same way as we treated the semaglutide and girl,” vigorous ingredients in Ozmpic and Zepbound. Fritzler claims that Olympia plans to start producing this summer.
GLP-1 drugs, such as Ozmpic and Zepbound, have been healed because of their unmatched success in the treatment of obesity and type 2 diabetes. Scientists believe that they can also facilitate patients suffering from many other conditions, from addiction to Parkinson. After exploding the demand for GLP-1 in recent years, FDA has declared that some of the names of the name brand were officially deficiencies. This meant that doctors could legally prescribe the cheaper “complex” versions of semaglutide and girls with the same vigorous ingredients as the originals.
Intricate pharmacies and teeth start-ups flourished the sale of these alternative GLP-1 online products, attracting millions of customers who could not afford or did not want to pay higher prices for brand medicines, which are often not covered by insurance. Now the deficiencies of both of these drugs have ended. The FDA grace period for producers to stop production and sales of the intricate tiring is over, and the date of cutting off the semaglutide is May 22. was missing From April 2023, so comprehensive people can continue it.
Some Teradrowia companies still offer intricate drugs, which they think are not technically direct copies of patented drugs because they are supplied in custom doses or with additional vitamins. Eli Lilly has already sued some of them, claiming that these versions are illegal. Other teens and complexes play it safely, completely stopping sales. (For example, Olympia stops semaglutide production.)